연구

연구업적

최근 5년 연구업적 현황
연도 2023년 2022년 2021년 2020년 2019년
SCI 논문
발표편수
책임 173편 163편 184편 135편 144편
공동 120편 115편 136편 168편 167편
합계 293편 278편 320편 303편 311편
3151. Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Catenacci DV, Kang YK, Uronis HE, Lee KW, Ng MC, Enzinger PC, Park SH, Gold PJ, Lacy J, Hochster HS, Oh SC, Kim YH, Marrone KA, Kelly RJ, Juergens RA, Kim JG, Alcindor T, Sym SJ, Song EK, Chee CE, Chao Y, Kim S, Oh DY, Yen J, Odegaard JI, Lagow E, Li D, Sun J, Kaminker P, Moore PA, Rosales MK, Park H.
Oncology (Williston Park). 2023 Apr 25;37(4):176-183. Link
3150. Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial.
Tempero MA, Pelzer U, O'Reilly EM, Winter J, Oh DY, Li CP, Tortora G, Chang HM, Lopez CD, Bekaii-Saab T, Ko AH, Santoro A, Park JO, Noel MS, Frassineti GL, Shan YS, Dean A, Riess H, Van Cutsem E, Berlin J, Philip P, Moore M, Goldstein D, Tabernero J, Li M, Ferrara S, Le Bruchec Y, Zhang G, Lu B, Biankin AV, Reni M; APACT Investigators.
J Clin Oncol. 2023 Apr 10;41(11):2007-2019. Link
3149. Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial.
Bekaii-Saab T, Okusaka T, Goldstein D, Oh DY, Ueno M, Ioka T, Fang W, Anderson EC, Noel MS, Reni M, Choi HJ, Goldberg JS, Oh SC, Li CP, Tabernero J, Li J, Foos E, Oh C, Van Cutsem E.
EClinicalMedicine. 2023 Mar 16;58:101897. Link
3148. Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study.
Borad MJ, Bai LY, Richards D, Mody K, Hubbard J, Rha SY, Soong J, McCormick D, Tse E, O'Brien D, Bayat A, Ahn D, Davis SL, Park JO, Oh DY.
Hepatology. 2023 Mar 1;77(3):760-773. Link
3147. Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, Morizane C, Karasic TB, Abrams TA, Furuse J, Kelley RK, Cassier PA, Klümpen HJ, Chang HM, Chen LT, Tabernero J, Oh DY, Mahipal A, Moehler M, Mitchell EP, Komatsu Y, Masuda K, Ahn D, Epstein RS, Halim AB, Fu Y, Salimi T, Wacheck V, He Y, Liu M, Benhadji KA, Bridgewater JA; FOENIX-CCA2 Study Investigators.
N Engl J Med. 2023 Jan 19;388(3):228-239. Link
3146. Predictive Value of KLASS-02-QC Assessment Score on KLASS-02 Surgical Outcomes: Validation of Surgeon Quality Control and Standardization for D2 Lymphadenectomy.
Song JH, Shin HJ, Hyung WJ, Yang HK, Han SU, Park YK, Lee HJ, An JY, Kim W, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Kim JJ, Park DJ, Kim YW, Ryu KW, Kim JW, Lee JH, Kim HI.
Ann Surg. 2023 Nov 1;278(5):e1011-e1017. Link
3145. Textbook outcome in oncological gastric surgery: a systematic review and call for an international consensus.
Carbonell-Morote S, Yang HK, Lacueva J, Rubio-García JJ, Alacan-Friedrich L, Fierley L, Villodre C, Ramia JM.
World J Surg Oncol. 2023 Sep 12;21(1):288. Link
3144. Effects of Neutrophil and Eosinophil Extracellular Trap Formation on Refractoriness in Chronic Rhinosinusitis With Nasal Polyps
Cha H, Lim HS, Park JA, Jo A, Ryu HT, Kim DW, Kim JK, Hong SN, Shin HW, Kim DW. 
Allergy Asthma Immunol Res. 2023 Jan;15(1):94-108. Link
3143. Soybean product consumption decreases risk of gastric cancer: results from the Health Examinees Study
Woo-Kyoung Shin 1 2, Hwi-Won Lee 1 3, Dan Huang 1 2, Katherine De la Torre 1 3, Sukhong Min 1, Aesun Shin 1 4, Jong-Koo Lee 5, Jung Eun Lee 6, Daehee Kang 7 8
Eur J Nutr . 2023 Jun;62(4):1743-1753 Link
3142. Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees Study
Dan Huang 1 2, Woo-Kyoung Shin 1 2, Katherine De la Torre 1 3, Hwi-Won Lee 1 3, Sukhong Min 1, Aesun Shin 1 2 4, Jong-Koo Lee 5, Daehee Kang 6 7
Gastric Cancer . 2023 Jul;26(4):481-492. Link